-
Avalon Tech
2,171.00 778.15(%) -
Bharti Airtel
1,753.30 1,745.00(%) -
NSE
1,761.00 1,761.00(%) -
Molbio Diagnosti
1,368.00 1,686.50(%) -
Apollo Hospitals
8,063.00 6,680.00(%) -
Innova Captab
1,080.00 608.25(%) -
Hero Motors
152.58 156.03(%) -
Meesho
230.55 254.65(%) -
Azad Engineering
3,126.00 3,126.00(%) -
Shadowfax Technologies
278.10 98.60(%) -
Cupid
312.10 312.10(%) -
L&T Finance Ltd
264.75 234.90(%) -
Lenskart Solut.
698.00 725.00(%) -
Reliance Industries
1,196.30 1,611.20(%) -
SS Retail
761.45 888.00(%) -
Sun TV Network
664.60 664.60(%) -
Solar Industries
19,820.00 22,630.05(%) -
PB Fintech.
1,040.00 1,040.00(%) -
National High
168.00 142.00(%) -
HDFC Bank
709.70 682.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Biocon Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 14801.0
- ISIN : INE376G01013
-
Today’s Low
370.30 -
Today’s High
381.20
-
Open
378.00 -
Perv Close
377.00 -
52W Low
337.05 -
52W High
447.15
Key Indicators
-
P/E(TTM)
200.54
-
Mar.Cap (₹Cr.)
60,347.57
-
Div & Yield %
0.13
-
Book Value(₹)
167.99
-
Debt-Equity Ratio
-1.78
-
AGM Date
30-Sep-2026
-
EPS
1.85
-
P/E Ratio
200.54
Financials Ratios
-
Debt-Equity Ratio
0.91
-
Mar.Cap (₹Cr.)
60,347.57
-
RONW (%)
6.89
-
ROCE (%)
6.35
Score Board
-
Equity (₹ in Cr.)
814.85
-
BV (₹)
168.00
-
Sales( ₹ in Cr.)
2,346.40
-
NP (in Cr.)
175.30
-
NP Var(%)
445.0
-
Div%
10.0
-
CPS (₹)
1.90
-
EPS (₹)
1.10
-
Traded Value (₹ in Lakhs)
60,461.65
-
52 Week High
447.15
-
52 Week Low
337.05
-
Price BSE
371.0
-
Price NSE
370.00
-
Market Capital( in Cr.)
60,461.65
-
P/C Ratio
193.40
-
P/E Ratio
344.90
-
Price Vs.BV
1.10
-
30-Sep-2026( 09:00)
Corporate News - Bioco... - <p>Biocon Limited informed the...
-
21-Sep-2026( 01:05)
Hot Pursuit - Bioco... - <p>Biocon Ltd is up for a thir...
-
09-Sep-2026( 11:00)
Hot Pursuit - Volum... - <p>OneSource Specialty Pharma...
-
06-Aug-2026( 10:34)
Corporate News - Bioco... - Biocon Limited announced chang...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 2,346.40 | 2,242.60 | 2,127.30 | 1,992.90 | 1,738.20 | 2,028.40 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,346.40 | 2,242.60 | 2,127.30 | 1,992.90 | 1,738.20 | 2,028.40 |
| Other Income | 319.70 | 849.80 | 207.50 | 3,134.20 | 187.20 | 150.20 |
| Stock Adjustments | 118.70 | 54.60 | 99.10 | -3.20 | 105.80 | -36.70 |
| Total Income | 2,784.80 | 3,147.00 | 2,433.90 | 5,123.90 | 2,031.20 | 2,141.90 |
| EXPENDITURE : | ||||||
| Raw Materials | 1,187.60 | 1,085.40 | 1,033.80 | 981.00 | 914.00 | 761.60 |
| Power and Fuel Cost | 215.80 | 192.00 | 215.30 | 279.20 | 231.00 | 186.00 |
| Employee Cost | 467.20 | 501.30 | 452.30 | 433.80 | 367.70 | 390.20 |
| Other Manufacturing Expenses | 165.90 | 150.70 | 155.40 | 127.10 | 130.50 | 147.00 |
| Selling and Administration Expenses | 193.20 | 172.00 | 135.00 | 112.20 | 106.70 | 128.40 |
| Miscellaneous Expenses | 224.40 | 20.00 | -28.10 | 32.90 | 33.00 | 66.00 |
| Employee Benefit Expenses | 467.20 | 501.30 | 452.30 | 433.80 | 367.70 | 390.20 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 2,454.10 | 2,121.40 | 1,963.70 | 1,966.20 | 1,782.90 | 1,679.20 |
| Operating Profit | 330.70 | 1,025.60 | 470.20 | 3,157.70 | 248.30 | 462.70 |
| Interest | 142.40 | 236.90 | 198.80 | 69.60 | 0.40 | 0.40 |
| Gross Profit | 188.30 | 788.70 | 271.40 | 3,088.10 | 247.90 | 462.30 |
| Depreciation | 137.30 | 127.80 | 121.10 | 116.90 | 108.20 | 103.50 |
| Profit Before Tax | 51.00 | 660.90 | 150.30 | 2,971.20 | 139.70 | 358.80 |
| Current Tax | 12.00 | 30.60 | 15.10 | 132.70 | 60.70 | 73.50 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.80 | 21.00 | 15.90 | -9.90 | -7.10 | 4.80 |
| Reported Net Profit | 37.20 | 609.30 | 119.30 | 2,848.40 | 86.10 | 280.50 |
| Extraordinary Items | -138.10 | 660.11 | 13.41 | 2,861.73 | 2.92 | 3.00 |
| Adjusted Net Profit | 175.30 | -50.81 | 105.89 | -13.33 | 83.18 | 277.50 |
| Adjustment below Net Profit | -23.50 | -1.30 | 30.70 | 29.40 | -59.40 | 30.40 |
| P & L Balance brought forward | 10,468.50 | 9,920.50 | 9,950.60 | 7,132.80 | 7,106.10 | 6,795.20 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 66.80 | 60.00 | 180.10 | 60.00 | 0.00 | 0.00 |
| P & L Balance carried down | 10,415.40 | 10,468.50 | 9,920.50 | 9,950.60 | 7,132.80 | 7,106.10 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 10.00 | 10.00 | 10.00 | 30.00 | 10.00 | 0.00 |
| Dividend Per Share(Rs) | 0.50 | 0.50 | 0.50 | 1.50 | 0.50 | 0.00 |
| Earnings Per Share-Unit Curr | 0.23 | 5.07 | 0.99 | 23.72 | 0.72 | 2.34 |
| Earnings Per Share(Adj)-Unit Curr | 0.23 | 5.07 | 0.99 | 23.72 | 0.72 | 2.34 |
| Book Value | 166.85 | 96.63 | 90.88 | 90.91 | 67.40 | 65.88 |
| Book Value(Adj)-Unit Curr | 166.85 | 96.63 | 90.88 | 90.91 | 67.40 | 65.88 |
